Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 13th, there was short interest totaling 5,609 shares, a decrease of 44.7% from the February 26th total of 10,141 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average trading volume of 22,212 shares, the days-to-cover ratio is presently 0.3 days.
Institutional Trading of Invesco Nasdaq Biotechnology ETF
A number of institutional investors have recently added to or reduced their stakes in IBBQ. Royal Bank of Canada purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $37,000. International Assets Investment Management LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at approximately $41,000. MMA Asset Management LLC purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter worth approximately $51,000. Advisory Services Network LLC purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter worth approximately $52,000. Finally, Osaic Holdings Inc. grew its holdings in shares of Invesco Nasdaq Biotechnology ETF by 28.4% in the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after acquiring an additional 1,052 shares during the period.
Invesco Nasdaq Biotechnology ETF Stock Performance
Shares of NASDAQ IBBQ opened at $28.42 on Friday. The firm has a market capitalization of $71.33 million, a P/E ratio of 17.03 and a beta of 0.67. Invesco Nasdaq Biotechnology ETF has a one year low of $17.84 and a one year high of $30.49. The company’s fifty day moving average is $29.22 and its two-hundred day moving average is $27.67.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Read More
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
